Jounce Therapeutics (JNCE)

6.66 -0.09 (1.33%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/18 *Est.)

Latest Headlines

Form 4 Jounce Therapeutics, For: Sep 06 Filed by: MURRAY RICHARD /CA/ September 7, 2018 4:49 PM - SEC Filing Jounce Therapeutics to Present at Upcoming Investor Conferences in September August 29, 2018 8:00 AM - Globe NewsWire Form 4 Jounce Therapeutics, For: Aug 27 Filed by: Drapkin Kimberlee C August 28, 2018 5:31 PM - SEC Filing Form 4 Jounce Therapeutics, For: Aug 13 Filed by: Trehu Elizabeth August 15, 2018 5:29 PM - SEC Filing Form 4 Jounce Therapeutics, For: Aug 13 Filed by: Cole Hugh M August 15, 2018 5:29 PM - SEC Filing Form 4 Jounce Therapeutics, For: Aug 13 Filed by: Drapkin Kimberlee C August 15, 2018 5:28 PM - SEC Filing Jounce Therapeutics (JNCE) PT Lowered to $13 at H.C. Wainwright August 13, 2018 7:51 AM - StreetInsider Form 10-Q Jounce Therapeutics, For: Jun 30 August 9, 2018 1:54 PM - SEC Filing Jounce Therapeutics (JNCE) PT Lowered to $15 at Baird August 9, 2018 11:11 AM - StreetInsider Form 8-K Jounce Therapeutics, For: Aug 09 August 9, 2018 7:21 AM - SEC Filing Jounce Therapeutics (JNCE) Reports Q2 Loss of $0.14/Share August 9, 2018 6:36 AM - StreetInsider Jounce Therapeutics Reports Second Quarter 2018 Financial Results August 9, 2018 6:30 AM - Globe NewsWire Jounce Therapeutics to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018 August 2, 2018 8:00 AM - Globe NewsWire Raymond James Starts Jounce Therapeutics (JNCE) at Outperform June 27, 2018 5:51 PM - StreetInsider Full Article List